Andrew Joseph

Barney Graham, a former NIH vaccine developer, said U.S. agencies aren't coordinating the response to the bird flu outbreak among cows.

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion

The Nobel-winning scientists opened new doors in our understanding of the structure of proteins and came up with ways to create new proteins.

Two pioneers behind machine learning — a technology that is already transforming society and that carries profound ethical questions — won the Nobel Prize in physics.

Two scientists who discovered a type of RNA molecule that helps control the activity of genes have won the 2024 Nobel Prize in medicine.

Chinese drugmakers targeted by forthcoming U.S. national security legislation are working on sales of some operations

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight loss drugs means there is room for more players.

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

What Pfizer’s decision to pull its sickle cell drug means for patients, the company, and the FDA.

Celldex drug reduces chronic hive activity, but patient discontinuations raise questions